Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1281
-
1282
-
1283
-
1284
-
1285
-
1286
-
1287
-
1288
-
1289
-
1290
Loss of virulence in the SIN kinase mutants is characterized by decreased fungal burden and host response to infection.
Published 2021“…Quantitation of IL-1β <b>(B)</b> and TNFα <b>(C)</b> revealed decreased host response in SIN kinase mutant infected mice. …”
-
1291
-
1292
Decrease in number of activated macrophages in demyelinated nerves subjected to 1hr ES.
Published 2014“…Note: ES results in a significant decrease in the ED-1 IF 10d post-LPC (5d post-ES; K) and 12d post-LPC (7d post-ES; N) relative to LPC only in a pattern suggestive of movement toward lateral edges and egress (arrow). …”
-
1293
Phosphorylated ERK (ERK-P) is decreased in terminally prion-diseased PrP<sup>C</sup>GPIThy-1 L150 mice.
Published 2019“…For the quantification, each signal was first related to the corresponding actin signal. Note that there is a significant decrease in ERK-P signal (*<i>p</i> = 0.031) in PrP<sup>C</sup>GPIThy-1 RML infected mice compared to WTPrP<sup>C</sup> mice, whereas no changes are observed for p38-P.…”
-
1294
Shedding of PrP is decreased in PrP<sup>C</sup>GPIThy-1 L150 mice but increases after RML infection.
Published 2019“…WTPrP<sup>C</sup> is set to 100%. Note that shedding in PrP<sup>C</sup>GPIThy-1 L150 is still decreased compared to WTPrP<sup>C</sup> (***<i>p</i> = 0.0004). …”
-
1295
-
1296
-
1297
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6
Published 2017“…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”
-
1298
-
1299
-
1300